Polymyxin B sulfate: Difference between revisions
Created page with "__NOTOC__ {{Polymyxin B sulfate}} {{CMG}}; {{AE}} {{MM}} ==Overview== ==Category== Polymyxin antibiotic ==US Brand Names== NEOSPORIN<sup>®</sup> ==FDA Packag..." |
Gerald Chi (talk | contribs) mNo edit summary |
||
| (10 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Polymyxin B sulfate}} | {{Polymyxin B sulfate}} | ||
'''''For patient information, click <u>[[Neomycin, polymyxin, and bacitracin topical (patient information)|here]]</u> and <u>[[Neomycin, polymyxin, and bacitracin ophthalmic (patient information)|here]]</u>'''''. | |||
{{CMG}}; {{AE}} {{MM}} | {{CMG}}; {{AE}} {{MM}} | ||
==Overview== | ==Overview== | ||
'''Neosporin''' is an antibiotic product marketed for the prevention of [[infection]]s and speeding the healing of [[wound]]s. | |||
The original ointment contains three different antibiotics: [[bacitracin]], [[neomycin]], and [[polymyxin B]], in a relatively low molecular weight patented base of cocoa butter, cottonseed oil, sodium pyruvate, tocopheryl acetate, and [[petroleum jelly]]. | |||
==Category== | ==Category== | ||
| Line 18: | Line 23: | ||
'''| [[Polymyxin B sulfate warnings and precautions|Warnings and Precautions]]''' | '''| [[Polymyxin B sulfate warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Polymyxin B sulfate adverse reactions|Adverse Reactions]]''' | '''| [[Polymyxin B sulfate adverse reactions|Adverse Reactions]]''' | ||
'''| [[Polymyxin B sulfate dosage and administration|Dosage and Administration]]''' | '''| [[Polymyxin B sulfate dosage and administration|Dosage and Administration]]''' | ||
'''| [[Polymyxin B sulfate how supplied|How Supplied]]''' | '''| [[Polymyxin B sulfate how supplied|How Supplied]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
[[Polymyxin|Polymyxin antibiotic]] is a surface active agent which penetrates into and disrupts the bacterial cell membrane. It has been shown to have bactericidal activity against most strains of the microorganisms.<ref name="dailymed.nlm.nih.gov">{{Cite web | last = | first = | title = NEOSPORIN (NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN) SOLUTION [MONARCH PHARMACEUTICALS, INC.] | url = http://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=33e9b6d3-2b2b-4036-dd89-47177e23fcfe | publisher = | date = | accessdate}}</ref> | |||
==References== | ==References== | ||
Latest revision as of 17:54, 8 January 2014
For patient information, click here and here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Neosporin is an antibiotic product marketed for the prevention of infections and speeding the healing of wounds. The original ointment contains three different antibiotics: bacitracin, neomycin, and polymyxin B, in a relatively low molecular weight patented base of cocoa butter, cottonseed oil, sodium pyruvate, tocopheryl acetate, and petroleum jelly.
Category
US Brand Names
NEOSPORIN®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Dosage and Administration | How Supplied
Mechanism of Action
Polymyxin antibiotic is a surface active agent which penetrates into and disrupts the bacterial cell membrane. It has been shown to have bactericidal activity against most strains of the microorganisms.[1]
References
- ↑ "NEOSPORIN (NEOMYCIN AND POLYMYXIN B SULFATES AND GRAMICIDIN) SOLUTION [MONARCH PHARMACEUTICALS, INC.]". Text " accessdate" ignored (help)